Influence of blood sampling on protein profiling and pattern analysis using matrix-assisted laser desorption/ionisation mass spectrometry

BJU International

Volumn 99, Issue 3, 2007, Pages 658-662

  Pelzer, Alexandre E ^a   Feuerstein, Isabel ^b   Fuchsberger, Christian ^a   Ongarello, Stefano ^b,c   Bektic, Jasmin ^a   Schwentner, Christian ^a   Klocker, Helmut ^a   Bartsch, George ^a   Bonn, Guenther K ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Prostate cancer; Protein profiling; Proteomics

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; HUMAN; KOLMOGOROV SMIRNOV TEST; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VEIN PUNCTURE; VENOUS BLOOD;

DECISION TREES; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33846921589     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06678.x     Document Type: Article

References (22)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-9
2. Thompson IM, Pauler DK, Goodman PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004; 350: 2239-46
3. Carter HB, Isaacs WB. Improved biomarkers for prostate cancer: a definite need. J Natl Cancer Inst 2004; 96: 813-5
4. Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004; 3: 311-26
5. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003; 2: 1096-103
6. Zhou M, Lucas DA, Chan KC et al. An investigation into the human serum 'interactome'. Electrophoresis 2004; 25: 1289-98
7. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004; 20: 777-85
8. Coombes KR, Fritsche HA Jr, Clarke C et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem 2003; 49: 1615-23
9. Jock CA, Paulauskis JD, Baker D et al. Influence of matrix application timing on spectral reproducibility and quality in SELDI-TOF-MS. Biotechniques 2004; 37: 30-2
10. Rogers MA, Clarke P, Noble J et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 2003; 63: 6971-83
11. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P. Urine protein profiling with surface-enhanced laserdesorption/ionization time-of-flight mass spectrometry. Kidney Int 2004; 65: 323-32
12. Feuerstein I, Rainer M, Katussevani B et al. Derivated Cellulose Combined with MALDI-TOF-MS: A New Tool for Serum Protein Profiling. J Proteome Res 2005; 4: 2320-6
13. Pelzer A, Bektic J, Berger AP et al. Prostate cancer detection in men with prostate specific antigen 4-10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 2005; 173: 1926-9
14. Wong JW, Cagney G, Cartwright HM. SpecAlign - processing and alignment of mass spectra datasets. Bioinformatics 2005; 21: 2088-90
15. Frank E, Hall M, Trigg L, Holmes G, Witten IH. Data mining in bioinformatics using Weka. Bioinformatics 2004; 20: 2479-81
16. Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004; 3: 367-78
17. Sorace JM, Zhan M. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 2003; 4: 24
18. Diamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004; 96: 353-6
19. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002; 41: 391-412
20. Banks RE, Stanley AJ, Cairns DA et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. Clin Chem 2005; 51: 1637-49
21. Smets EM, Dijkstra-Lagemaat JE, Blankenstein MA. Influence of blood collection in plastic vs glass evacuated serum-separator tubes on hormone and tumour marker levels. Clin Chem Lab Med 2004; 42: 435-9
22. Drake SK, Bowen RA, Remaley AT, Hortin GL. Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. Clin Chem 2004; 50: 2398-401